Stock 911 QIANHAI HEALTH HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Qianhai Health Holdings Limited

Equities

911

KYG7307F1046

Drug Retailers

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.04 HKD -4.76% Intraday chart for Qianhai Health Holdings Limited +21.21% +8.11%
Mar. 15 Qianhai Health's Loss Shrinks in 2023 MT
Mar. 14 Qianhai Health Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 1,479 431.7 326.7 203.1 127.1 149.1
Enterprise Value (EV) 1 1,303 285.7 382.7 210.6 132.3 148.5
P/E ratio 41.3 x 85.3 x 12.2 x -253 x -143 x -0.64 x
Yield 1.15% - - - - -
Capitalization / Revenue 7.51 x 5.53 x 0.56 x 0.27 x 0.45 x 0.08 x
EV / Revenue 6.61 x 3.66 x 0.65 x 0.28 x 0.47 x 0.08 x
EV / EBITDA -65.6 x -6.48 x 30 x 47.2 x -9.23 x -0.92 x
EV / FCF -12.5 x -2.86 x -1.73 x -4.01 x -0.98 x 1.23 x
FCF Yield -7.99% -34.9% -57.8% -24.9% -102% 81.1%
Price to Book 2.22 x 0.68 x 0.49 x 0.3 x 0.19 x 0.34 x
Nbr of stocks (in thousands) 1,700,405 1,692,760 1,692,760 1,692,760 1,694,450 1,694,450
Reference price 2 0.8700 0.2550 0.1930 0.1200 0.0750 0.0880
Announcement Date 4/19/18 4/25/19 4/28/20 4/21/21 4/29/22 4/27/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 197.1 78.05 587.8 760.7 283.4 1,962
EBITDA 1 -19.85 -44.11 12.77 4.458 -14.33 -162.2
EBIT 1 -23.02 -45.97 11.32 2.334 -16.06 -163.9
Operating Margin -11.68% -58.9% 1.93% 0.31% -5.67% -8.36%
Earnings before Tax (EBT) 1 35.92 -5.016 26.72 -0.804 -0.888 -233.7
Net income 1 35.86 5.071 26.72 -0.804 -0.888 -233.7
Net margin 18.2% 6.5% 4.54% -0.11% -0.31% -11.91%
EPS 2 0.0211 0.002988 0.0158 -0.000474 -0.000524 -0.1379
Free Cash Flow 1 -104.1 -99.78 -221.4 -52.48 -134.5 120.4
FCF margin -52.83% -127.85% -37.66% -6.9% -47.45% 6.14%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.0100 - - - - -
Announcement Date 4/19/18 4/25/19 4/28/20 4/21/21 4/29/22 4/27/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 56 7.45 5.19 -
Net Cash position 1 177 146 - - - 0.63
Leverage (Debt/EBITDA) - - 4.389 x 1.672 x -0.362 x -
Free Cash Flow 1 -104 -99.8 -221 -52.5 -134 120
ROE (net income / shareholders' equity) 5.55% 0.77% 4.12% -0.12% -0.13% -42.2%
ROA (Net income/ Total Assets) -2% -3.86% 0.96% 0.19% -1.36% -16.1%
Assets 1 -1,789 -131.3 2,791 -419.4 65.23 1,452
Book Value Per Share 2 0.3900 0.3800 0.3900 0.4000 0.4000 0.2600
Cash Flow per Share 2 0.1100 0.0800 0.0100 0.0100 0 0
Capex 1 6.24 28.5 33.1 0.01 0.01 0
Capex / Sales 3.16% 36.52% 5.64% 0% 0% 0%
Announcement Date 4/19/18 4/25/19 4/28/20 4/21/21 4/29/22 4/27/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Drug Retailers

1st Jan change Capi.
QIANHAI HEALTH HOLDINGS LIMITED Stock Qianhai Health Holdings Limited
+8.11% 8.66M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.21% 15.27B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-31.97% 10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.42% 6.06B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+8.14% 6.04B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.41% 5.86B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-1.17% 4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+52.19% 4.29B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-14.86% 3.33B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-6.93% 3.01B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 911 Stock
  4. Financials Qianhai Health Holdings Limited